ACE2 and metabolic syndrome: Many studies have reported that ACE2/Ang (1-7) axis attenuates the manifestations of MetS by reducing the amount of fat tissue and plasma lipid levels and enhancing glucose tolerance and insulin sensitivity (Santos et al., 2010; Liu et al., 2012).